Quest Diagnostics Incorporated

DGX · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.4%

Institutions99.2%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$11.04B	$9.87B	$9.25B	$9.88B	$10.79B	$9.44B	$7.73B	$7.53B	$7.71B	$7.51B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$7.37B	$6.63B	$6.20B	$6.45B	$6.58B	$5.80B	$5.04B	$4.93B	$4.72B	$4.62B
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$1.56B	$1.35B	$1.26B	$1.43B	$2.38B	$1.97B	$1.23B	$1.10B	$1.17B	$1.28B
Operating income as a percentage of revenue.	14.1%	13.6%	13.6%	14.4%	22.1%	20.9%	15.9%	14.6%	15.1%	17.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$54.00M	$50.00M	$54.00M	$69.00M	$85.00M	$68.00M	$48.00M	$736.00M	$772.00M	$645.00M
Net income divided by the number of shares outstanding — profit attributable to each share.	$8.87	$7.78	$7.59	$8.10	$15.85	$10.62	$6.36	$5.00	$5.00	$4.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$8.75	$7.69	$7.49	$7.97	$15.55	$10.47	$6.28	$5.00	$5.00	$4.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$420.00M	$549.00M	$686.00M	$315.00M	$872.00M	$1.16B	$1.19B	$135.00M	$137.00M	$359.00M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$16.23B	$16.15B	$14.02B	$12.84B	$13.61B	$14.03B	$12.84B	$11.00B	$10.50B	$10.10B
All of the company's interest-bearing borrowings, short and long term combined.	$504.00M	$602.00M	$303.00M	$2.00M	$2.00M	$2.00M	$804.00M	$464.00M	$36.00M	$6.00M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$7.17B	$6.78B	$6.31B	$5.89B	$6.44B	$6.76B	$5.64B	$5.22B	$4.92B	$4.63B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$1.89B	$1.33B	$1.27B	$1.72B	$2.23B	$2.00B	$1.24B	$1.20B	$1.18B	$1.07B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$527.00M	$425.00M	$408.00M	$404.00M	$403.00M	$418.00M	$400.00M	$383.00M	$252.00M	$293.00M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$1.36B	$909.00M	$864.00M	$1.31B	$1.83B	$1.59B	$843.00M	$817.00M	$923.00M	$776.00M

	You	Peer avg
P/E	25.2	21.3
Revenue Growth	+10.2%	+16.0%
ROE	14.6%	11.6%

Quest Diagnostics Incorporated

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison